Ames -- A team of U.S. scientists has identified a way of possibly neutralizing an enzyme that helps make tuberculosis resistant to a human's natural defense system.
New York, February 27: Meropenem and clavulanate, two FDA-approved antibiotics, when used in combination, appear to offer great promise against the deadly, extremely drug-resistant tuberculosis (XDR-TB), a new American study claims.
Disclaimer: The views and investment tips expressed by investment experts on themoneytimes.com are their own, and not that of the website or its management. TheMoneyTimes advises users to check with certified experts before taking any investment decision.
Recent comments
26 min 57 sec ago
1 hour 3 min ago
1 hour 7 min ago
14 hours 42 min ago
1 day 13 hours ago
1 day 15 hours ago
1 day 16 hours ago
1 day 20 hours ago
2 days 8 hours ago
2 days 22 hours ago